Nissan Medical Industries Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	651.78	664.08	733.91	684.65	668.37
Revenue Growth (YoY)	-1.85%	-9.52%	7.20%	2.44%	-7.36%
Cost of Revenue	563.41	566.06	598.14	601.37	523.95
Gross Profit	88.37	98.02	135.78	83.28	144.42
Selling, General & Admin	66.61	68.35	73.14	85.19	78.54
Other Operating Expenses	-4.02	-0.01	1.26	-0.15	0.07
Operating Expenses	62.59	68.35	74.4	85.04	78.61
Operating Income	25.78	29.68	61.37	-1.77	65.81
Interest Expense	-11.99	-13.34	-21.27	-10.02	-7.28
Interest & Investment Income	0.26	0.47	0.18	0.01	-
Earnings From Equity Investments	0.18	1.3	-7.06	-0.64	4.62
Currency Exchange Gain (Loss)	-0.58	1.51	0.05	-8.33	3.19
Other Non Operating Income (Expenses)	-3.99	-4.46	-5.47	-2.44	-1.28
EBT Excluding Unusual Items	9.66	15.15	27.81	-23.18	65.06
Impairment of Goodwill	-	-	-	-23.79	-
Gain (Loss) on Sale of Investments	0.37	0	0.01	-0.05	5.39
Pretax Income	10.02	15.15	27.82	-47.02	70.45
Income Tax Expense	1.33	1.35	8.78	0.27	13.29
Earnings From Continuing Operations	8.7	13.8	19.04	-47.29	57.16
Minority Interest in Earnings	-4.52	-5.9	-13.39	11.24	-21.14
Net Income	4.17	7.91	5.65	-36.05	36.01
Net Income to Common	4.17	7.91	5.65	-36.05	36.01
Net Income Growth	-47.22%	39.95%	-	-	-36.65%
Shares Outstanding (Basic)	9	9	9	9	9
Shares Outstanding (Diluted)	9	9	9	9	9
EPS (Basic)	0.46	0.87	0.62	-3.97	3.96
EPS (Diluted)	0.46	0.87	0.62	-3.97	3.93
EPS Growth	-47.20%	39.90%	-	-	-37.13%
Free Cash Flow	36.53	20.74	95.9	2.49	9.82
Free Cash Flow Per Share	4.02	2.28	10.56	0.28	1.08
Dividend Per Share	1.820	0.750	-	-	0.440
Dividend Growth	142.67%	-	-	-	-56.00%
Gross Margin	13.56%	14.76%	18.50%	12.16%	21.61%
Operating Margin	3.96%	4.47%	8.36%	-0.26%	9.85%
Profit Margin	0.64%	1.19%	0.77%	-5.27%	5.39%
Free Cash Flow Margin	5.60%	3.12%	13.07%	0.36%	1.47%
EBITDA	48.45	53	92.52	26.88	91.4
EBITDA Margin	7.43%	7.98%	12.61%	3.93%	13.68%
D&A For EBITDA	22.67	23.32	31.14	28.65	25.6
EBIT	25.78	29.68	61.37	-1.77	65.81
EBIT Margin	3.96%	4.47%	8.36%	-0.26%	9.85%
Effective Tax Rate	13.25%	8.92%	31.56%	-	18.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.